Trauma‐related symptoms ‐ post‐intervention ‐ not reported · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Psychological well‐being (secondary outcome) Not addressed · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
1 finding from 1 review
Substance use ‐ post‐intervention ‐ not reported · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Parent relationship quality ‐ not reported · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Parental self‐harm ‐ post‐intervention ‐ not reported · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Parent–child relationship ‐ not reported · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Parenting skills; postintervention · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in vertigo frequency · Ménière’s disease
It is very uncertain whether betahistine changes improvement in vertigo frequency compared with placebo/no treatment (very low certainty).
2 findings from 1 review
Vertigo (global score) at < 3 months · Ménière’s disease
1 finding from 1 review
Change in vertigo frequency · Ménière’s disease
2 findings from 1 review
Serious adverse events · Ménière’s disease
It is very uncertain whether betahistine changes serious adverse events compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Improvement in vertigo frequency · Ménière’s disease
It is very uncertain whether diuretic changes improvement in vertigo frequency compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Change in vertigo frequency · Ménière’s disease
1 finding from 1 review
Improvement in vertigo · people with vestibular migraine
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in vertigo frequency · people with vestibular migraine
1 finding from 1 review
Serious adverse events · people with vestibular migraine
It is very uncertain whether beta‐blockers changes serious adverse events compared with placebo (very low certainty).
1 finding from 1 review
Improvement in vertigo severity · people with vestibular migraine
It is very uncertain whether calcium channel blockers changes improvement in vertigo severity compared with no intervention (very low certainty).
1 finding from 1 review
Improvement in vertigo frequency · people with vestibular migraine
It is very uncertain whether calcium channel blockers changes improvement in vertigo frequency compared with no intervention (very low certainty).
1 finding from 1 review
Change in vertigo frequency · people with vestibular migraine
1 finding from 1 review
Serious adverse events · people with vestibular migraine
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found